OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacovigilance study for SGLT 2 inhibitors- Safety review of real-world data & randomized clinical trials
Karan B. Bhanushali, Heena Asnani, Ambica Nair, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 9, pp. 102664-102664
Open Access | Times Cited: 6
Karan B. Bhanushali, Heena Asnani, Ambica Nair, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 9, pp. 102664-102664
Open Access | Times Cited: 6
Showing 6 citing articles:
The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database
Huiping Hu, Maochang Liu, Zhiwen Fu, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Huiping Hu, Maochang Liu, Zhiwen Fu, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Understanding the disease: euglycemic ketoacidosis with SGLT2 inhibitors
Jolan Malherbe, Damien du Cheyron, Xavier Valette
Intensive Care Medicine (2025)
Closed Access
Jolan Malherbe, Damien du Cheyron, Xavier Valette
Intensive Care Medicine (2025)
Closed Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Safety assessment of dapagliflozin: Real-world adverse event analysis based on the FAERS database from 2012 to 2023
Zhengxi Zhou, Xiaotian Yao
Heliyon (2024) Vol. 10, Iss. 12, pp. e33306-e33306
Open Access | Times Cited: 2
Zhengxi Zhou, Xiaotian Yao
Heliyon (2024) Vol. 10, Iss. 12, pp. e33306-e33306
Open Access | Times Cited: 2
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2024), Iss. 4, pp. 126-135
Open Access | Times Cited: 1
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2024), Iss. 4, pp. 126-135
Open Access | Times Cited: 1
Author’s Reply to Peronard and Mayntz: “SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect”
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
